In Reference to: "Cost and Utility of Thrombophilia Testing".

Main|Search|PHGKB

From CDC-Authored Genomics Publication Database

This database contains CDC-authored publications in public health genomics including infectious diseases, newborn screening, reproductive health, genetic testing, cancer, chronic diseases, birth defects and developmental disabilities, environmental and occupational health as well as laboratory, bioinformatics and statistical methods.

---

• In Reference to: "Cost and Utility of Thrombophilia Testing".
  Berse Brygida et al. Journal of hospital medicine 2017 Sep 12(9) 783
• A proposed approach to accelerate evidence generation for genomic-based technologies in the context of a learning health system.
  Lu Christine Y et al. Genetics in medicine : official journal of the American College of Medical Genetics 2017 Aug
• Accounting for differences in healthcare utilization and expenditures among US males with haemophilia by type of health insurance.
  Guh S et al. Haemophilia : the official journal of the World Federation of Hemophilia 2017 23(2) e147-e151
• Utilization of genetic tests: analysis of gene-specific billing in Medicare claims data.
  Lynch Julie A et al. Genetics in medicine : official journal of the American College of Medical Genetics 2017 Aug 19(8) 890-899
• Applied epidemiology and public health: are we training the future generations appropriately?
  Brownson Ross C et al. Annals of epidemiology 2016 Dec
• Optimizing Infant HIV Diagnosis in Resource-Limited Settings: Modeling the Impact of HIV DNA PCR Testing at Birth.
  Chiu Alexander et al. Journal of acquired immune deficiency syndromes (1999) 2016 Dec 73(4) 454-462
• Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study.
  Liu Jie et al. Lancet (London, England) 2016 Sep 388(10051) 1291-301
• Will Precision Medicine Improve Population Health?
  Khoury Muin J et al. JAMA 2016 Aug
• Genotypes of rubella virus and the epidemiology of rubella infections in the Democratic Republic of the Congo, 2004-2013.
  Pukuta Elizabeth et al. Journal of medical virology 2016 Oct (10) 1677-84
• The Use of Economic Evaluation to Inform Newborn Screening Policy Decisions: The Washington State Experience.
  Grosse Scott D et al. The Milbank quarterly 2016 94(2) 366-91
• Emergency Department Visits and Inpatient Admissions Associated with Priapism among Males with Sickle Cell Disease in the United States, 2006-2010.
  Dupervil Brandi et al. PloS one 2016 11(4) e0153257
• An Economic Evaluation of PulseNet: A Network for Foodborne Disease Surveillance.
  Scharff Robert L et al. American journal of preventive medicine 2016 Feb
• Cost-Effectiveness/Cost-Benefit Analysis of Newborn Screening for Severe Combined Immune Deficiency in Washington State.
  Ding Yao et al. The Journal of pediatrics 2016 Feb
• The health system impact of false positive newborn screening results for medium-chain acyl-CoA dehydrogenase deficiency: a cohort study.
  Karaceper Maria D et al. Orphanet journal of rare diseases 2016 Feb 1112
• Sustainable HIV treatment in Africa through viral-load-informed differentiated care.
  et al. Nature 2015 Dec (7580) S68-76
• A Cost-Effectiveness Analysis of a Pilot Neonatal Screening Program for Sickle Cell Anemia in the Republic of Angola.
  McGann Patrick T et al. The Journal of pediatrics 2015 Dec 167(6) 1314-9
• The cost-effectiveness of routine testing for Lynch syndrome in newly diagnosed patients with colorectal cancer in the United States: corrected estimates.
  Grosse Scott D et al. Genet. Med. 2015 Jun 17(6) 510-1
• Evolution of the "drivers" of translational cancer epidemiology: analysis of funded grants and the literature.
  Lam Tram Kim et al. Am. J. Epidemiol. 2015 Apr 1. 181(7) 451-8
• Lam et al. respond to "Driving for further evolution".
  Lam Tram Kim et al. American journal of epidemiology 2015 Apr 181(7) 463
• Estimates of utility weights in hemophilia: implications for cost-utility analysis of clotting factor prophylaxis.
  Grosse Scott D et al. Expert review of pharmacoeconomics & outcomes research 2015 Apr 15(2) 267-83
• Detection of co-colonization with Streptococcus pneumoniae by algorithmic use of conventional and molecular methods.
  Saha Sudipta et al. Vaccine 2015 Jan 29. 33(5) 713-8
• Clinical utility of gene-expression profiling in women with early breast cancer: an overview of systematic reviews.
  Marrone Michael et al. Genet. Med. 2015 Jul 2. 17(7) 519-32
• Public awareness of genetic nondiscrimination laws in four States and perceived importance of life insurance protections.
  Parkman Alicia A et al. J Genet Couns 2015 Jun 24(3) 512-21
• Modular laboratories--cost-effective and sustainable infrastructure for resource-limited settings.
  Bridges Daniel J et al. The American journal of tropical medicine and hygiene 2014 Dec (6) 1074-8
• Assessing value in biomedical research: the PQRST of appraisal and reward.
  Ioannidis John P A et al. JAMA 2014 Aug 312(5) 483-4
• A comparison of family financial and employment impacts of fragile X syndrome, autism spectrum disorders, and intellectual disability.
  Ouyang Lijing et al. Research in developmental disabilities 2014 Jul 35(7) 1518-27
• Development of a loop-mediated isothermal amplification method for detection of Histoplasma capsulatum DNA in clinical samples.
  Scheel Christina M et al. J. Clin. Microbiol. 2014 Feb 52(2) 483-8
• A public health economic assessment of hospitals' cost to screen newborns for critical congenital heart disease.
  Peterson Cora et al. Public Health Rep 129(1) 86-93
• Hydroxyurea is associated with lower costs of care of young children with sickle cell anemia.
  Wang Winfred C et al. Pediatrics 2013 Oct 132(4) 677-83
• The use of US health insurance data for surveillance of rare disorders: hereditary hemorrhagic telangiectasia.
  Grosse Scott D et al. Genet. Med. 2014 Jan 16(1) 33-9
• Comparative effectiveness research in cancer genomics and precision medicine: current landscape and future prospects.
  Simonds Naoko I et al. J. Natl. Cancer Inst. 2013 Jul 3. 105(13) 929-36
• Comparative effectiveness research in cancer: what has been funded and what knowledge gaps remain?
  Glasgow Russell E et al. J. Natl. Cancer Inst. 2013 Jun 5. 105(11) 766-73
• Provocative questions in cancer epidemiology in a time of scientific innovation and budgetary constraints.
  Lam Tram Kim et al. Cancer Epidemiol. Biomarkers Prev. 2013 Apr 22(4) 496-500
• CDC Grand Rounds: Newborn screening and improved outcomes.
  et al. MMWR. Morbidity and mortality weekly report 2012 Jun 61(21) 390-3
• Multilevel research and the challenges of implementing genomic medicine.
  Khoury Muin J et al. J. Natl. Cancer Inst. Monographs 2012 May 2012(44) 112-20
• Health care expenditures for Medicaid-covered males with haemophilia in the United States, 2008.
  Guh S et al. Haemophilia : the official journal of the World Federation of Hemophilia 2012 Mar 18(2) 276-83
• Healthcare expenditures for males with haemophilia and employer-sponsored insurance in the United States, 2008.
  Guh S et al. Haemophilia : the official journal of the World Federation of Hemophilia 2012 Mar 18(2) 268-75
• Optimization of a low cost and broadly sensitive genotyping assay for HIV-1 drug resistance surveillance and monitoring in resource-limited settings.
  Zhou Zhiyong et al. PLoS ONE 2011 6(11) e28184
• The role of health technology assessment in coverage decisions on newborn screening.
  Fischer Katharina E et al. International journal of technology assessment in health care 2011 Oct 27(4) 313-21
• Cost-effectiveness analysis of diagnostic options for pneumocystis pneumonia (PCP).
  Harris Julie R et al. PLoS ONE 2011 6(8) e23158
• Informational privacy, public health, and state laws.
  O'Connor Jean et al. Am J Public Health 2011 Oct 101(10) 1845-50
• Is there a need for PGxceptionalism?
  Khoury Muin J et al. Genet. Med. 2011 Oct 13(10) 866-7

Go to CDC-Authored Genomics Publication Database